Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-10-10
2008-03-04
Anderson, Rebecca (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S237200, C514S254010, C514S326000, C514S422000, C544S141000, C544S372000, C546S208000, C548S518000, C548S953000
Reexamination Certificate
active
07338947
ABSTRACT:
The present application describes modulators of MCP-1 of formula (I):or pharmaceutically acceptable salt forms thereof, useful for the prevention of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma, processes for preparing and intermediates thereof.
REFERENCES:
patent: 5356907 (1994-10-01), Clemence et al.
patent: 6011052 (2000-01-01), Padia et al.
patent: 6706712 (2004-03-01), Cherney
patent: 7183270 (2007-02-01), Cherney et al.
patent: 2003/0060459 (2003-03-01), Cherney et al.
patent: 2003/0216434 (2003-11-01), Cherney
patent: 2004/0110736 (2004-06-01), Cherney
patent: 2004/0186143 (2004-09-01), Carter et al.
patent: 2004/0235835 (2004-11-01), Carter
patent: 2004/0235836 (2004-11-01), Cherney
patent: WO 97/37975 (1997-10-01), None
patent: WO 97/44329 (1997-11-01), None
patent: WO 98/06703 (1998-02-01), None
patent: WO 98/08826 (1998-03-01), None
patent: WO 99/07351 (1999-02-01), None
patent: WO 99/07678 (1999-02-01), None
patent: WO 99/25686 (1999-05-01), None
patent: WO 9937304 (1999-07-01), None
patent: WO 99/40913 (1999-08-01), None
patent: WO 99/40914 (1999-08-01), None
patent: WO 00/46196 (2000-08-01), None
patent: WO 00/69815 (2000-11-01), None
patent: WO 00/69820 (2000-11-01), None
patent: WO 01/19939 (2001-03-01), None
patent: WO 02/04416 (2002-01-01), None
patent: WO 02/26734 (2002-04-01), None
patent: WO 02/50019 (2002-06-01), None
patent: WO 02/060859 (2002-08-01), None
patent: WO 02060859 (2002-08-01), None
patent: WO 02/075023 (2002-09-01), None
patent: WO 02/102372 (2002-12-01), None
patent: WO 03/43988 (2003-05-01), None
patent: WO 03075853 (2003-09-01), None
patent: WO 2004071449 (2004-08-01), None
patent: WO 2004098512 (2004-11-01), None
patent: WO 2004098516 (2004-11-01), None
Suga et al., “Glycosidase Antibodies Induced to Half-Chair Transition-State Analog,”J. Am. Chem. Soc., vol. 116, pp. 11197-11198, 1994.
Fujita et al., “Regiocontrolled Iodoaminocyclization Reaction of an Ambident Nucleophile Mediated by Basic Metallic Reagent,”J. Org. Chem., vol. 62 pp. 7330-7335, 1997.
Evans et al., “Synthesis and Dopamine Receptor Modulating Activity of Novel Peptidomimetics of L-Propyl-L-Leucyl-Glycinamide Featuring Alpha, Alpha-Di-substited Amino Acids”, Am. Chem. Soc., vol. 42, 1999, pp. 1441-1447.
U.S. Appl. No. 10/922,406, filed Aug. 19, 2004, Carter et al.
U.S. Appl. No. 10/923,619, filed Aug. 19, 2004, Carter et al.
U.S. Appl. No. 10/922,726, filed Aug. 19, 2004, Carter et al.
U.S. Appl. No. 10/923,538, filed Aug. 19, 2004, Carter et al.
Carter Percy H.
Cherney Robert J.
Duncia John V.
Gardner Daniel S.
Santella Joseph B.
Anderson Rebecca
Bristol-Myers Squibb Co.
Duncan Laurelee A.
Kosack Joseph R.
Vanatten Mary
LandOfFree
Cyclic derivatives as modulators of chemokine receptor activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic derivatives as modulators of chemokine receptor activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic derivatives as modulators of chemokine receptor activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3961806